Pembrolizumab Continues to Demonstrate Long-Term Efficacy in Melanoma

Press/Media: Press / Media

PeriodFeb 20 2018

Media coverage

1

Media coverage

  • TitlePembrolizumab Continues to Demonstrate Long-Term Efficacy in Melanoma
    Media name/outletOncLive
    CountryUnited States
    Date2/20/18
    PersonsEric Whitman